ExploreWatchlistsPricing
  1. JP-listed companies
  2. kainos loboratories,inc
  3. Financials
  4. Revenue growth (%)

kainos loboratories,inc (4556)

Market cap
¥10.4B
P/E ratio
16x
Kainos manufactures diagnostic pharmaceuticals, laboratory reagents, and medical devices for hospitals and research facilities to improve healthcare quality.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20263.3-33.47%
Mar 31, 20254.9+81.92%
Mar 31, 20242.7-59.49%
Mar 31, 20236.7-20.17%
Mar 31, 20228.4-209.83%
Mar 31, 2021-7.6+482.44%
Mar 31, 2020-1.3-120.22%
Mar 31, 20196.5-196.29%
Mar 31, 2018-6.7-43.96%
Mar 31, 2017-12+402.51%
Mar 31, 2016-2.4-57.55%
Mar 31, 2015-5.6-192.90%
Mar 31, 20146.1-51.40%
Mar 31, 201312.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat